Systemic Scleroderma Treatment Market Analysis: Driving Innovation in Chronic Disease Management
Systemic scleroderma, also known as systemic sclerosis, is a rare autoimmune disease characterized by excessive collagen production, progressive skin thickening, and damage to internal organs such as the lungs, heart, kidneys, and gastrointestinal tract. Although the condition remains incurable, advances in rheumatology therapeutics, the expanding rare disease treatment market, and...
0 Σχόλια 0 Μοιράστηκε 140 Views 0 Προεπισκόπηση